Nanosuspensions for intravenous administration

Details Nanosuspensions for intravenous administration Nanosuspensions for intravenous administration

A - Human Necessities

61

K

A61K 47/34 (2006.01) A61K 9/10 (2006.01) A61K 31/55 (2006.01) A61K 31/553 (2006.01) A61K 47/10 (2006.01) A61K 47/24 (2006.01)

Patent

CA 2172111

The present invention relates to a pharmaceutical composition for the intravenous admin- istration of the sparingly soluble staurosporin derivative N-benzoyl-staurosporin. The comp- osition comprises the following preferred components: a) the therpeutic agent N-benzoyl-staurosporin; b) a polyoxyethylene/polyoxypropylene block copolymer; c) ethanol and water as carrier liquids; and d) purified lecithin from soybeans and e) as water-soluble excipients glycerol and sorbitol.

Affiliated with

Also associated with

Rating

Nanosuspensions for intravenous administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nanosuspensions for intravenous administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanosuspensions for intravenous administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1619191